Bionematicides Global Market Report 2024

The bionematicides market size has grown rapidly in recent years. It will grow from $0.41 billion in 2023 to $0.47 billion in 2024 at a compound annual growth rate (CAGR) of 14.4%. The growth in the historic period can be attributed to increased awareness of environmental impacts from chemical pesticides, which spurred the shift towards biological solutions such as bionematicides. Advancements in microbial technology also facilitated the production of effective bionematicides. Regulatory pressures and bans on certain chemical nematicides further accelerated the market for biological alternatives. Additionally, rising consumer demand for organic produce contributed to this growth.

The bionematicides market size is expected to see rapid growth in the next few years. It will grow to $0.81 billion in 2028 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to increased adoption of sustainable farming practices, the expansion of commercial agriculture in emerging markets leading to greater use of biological solutions such as bionematicides, collaborations between biotech companies and agricultural institutions, integration of biocontrol agents into crop protection strategies, and a heightened focus on soil health and microbiome management. Major trends in this period include a surge in demand for environmentally friendly solutions, prompting significant innovation in bio-based formulations and biotechnology integration. There is also increased adoption of preventive nematode management strategies and sustainable agricultural practices.

The growth of the bionematicides market is expected to be propelled by the increasing adoption of greenhouse farming. Greenhouse farming involves growing crops in protected structures that are either fully or partially covered by transparent materials. This method is gaining popularity due to its ability to boost crop yields and ensure year-round production regardless of external climate conditions. Bionematicides play a crucial role in managing plant-parasitic nematodes (PPNs) in greenhouse farming, offering a sustainable and environmentally friendly alternative to chemical nematicides. For example, Agriculture and Agri-Food Canada reported in October 2023 that Canada witnessed 934 commercial greenhouse vegetable operations, yielding 752,685 metric tons of vegetables in 2022. This marked a 5% increase in operations and a 7% rise in production compared to 2021, indicating the growing adoption of greenhouse farming and its potential impact on the bionematicides market.

Leading companies in the bionematicides market are focusing on developing innovative products such as plant-parasitic nematicides to cater to customers with advanced features. Plant-parasitic nematicides are designed specifically to target and control plant-parasitic nematodes, which are microscopic roundworms that harm plants and cause significant crop damage. For instance, Corteva Inc. launched Reklemel Active in September 2023, a new nematicide aimed at protecting a wide range of food and row crops from plant-parasitic nematode damage. It achieves this without disturbing the healthy balance of beneficial organisms in the soil. Reklemel Active is one of the first new active ingredients to be registered under the EPA's updated policy, which includes Endangered Species Act assessments in the pesticide registration process.

In July 2023, CBC Europe Srl. acquired a stake in Ecospray Ltd., strengthening its position in the biocontrol market and expanding its product offerings. This strategic move enhances Ecospray Ltd.'s capabilities in providing bionematicides and biopesticides.

Major companies operating in the bionematicides market are BASF SE, Bayer AG, Syngenta AG, Corteva Agriscience, UPL Limited, FMC Corporation, Adama Agricultural Solutions Ltd., Novozymes A/S, Nufarm Limited, Chr. Hansen Holding A/S, Brandt, Isagro S.p.A., Koppert Biological Systems, T. Stanes and Company Limited, Certis USA LLC, Valent BioSciences Corporation, Marrone Bio Innovations Inc., The Real IPM Company, Andermatt Biocontrol AG, Bioworks Inc., Bio Huma Netics Inc., Horizon Agrotech.

North America was the largest region in the bionematicides market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bionematicides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bionematicides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Bionematicides are biological products derived from microorganisms such as fungi and bacteria, serving as bio-controlling agents against plant-parasitic nematodes. These microorganisms can capture, parasitize, disorient, and even paralyze nematodes at different developmental stages, offering a natural and environmentally friendly approach to nematode control.

The main types of bionematicides are microbial and biochemical. Microbial bionematicides use naturally occurring microorganisms such as bacteria, fungi, or protozoa to control nematodes and enhance plant health. They are available in forms such as dry and liquid bionematicides, suitable for crops such as cotton, corn, soybean, fruits, vegetables, and others. Various application methods include foliar spray, soil treatment, seed treatment, among others.

The bionematicides market research report is one of a series of new reports that provides bionematicides market statistics, including the bionematicides industry global market size, regional shares, competitors with the bionematicides market share, detailed bionematicides market segments, market trends, and opportunities, and any further data you may need to thrive in the bionematicides industry. These bionematicides market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bionematicides market consists of sales of bacillus-based bionematicides, paecilimyes, and lilacinus-based bionematicides. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.